Are locoregional cutaneous metastases in melanoma predictable

Annals of Surgical Oncology

Volumn 6, Issue 3, 1999, Pages 315-321

  Borgstein, Paul J ^a   Meijer, Sybren ^a   Van Diest, Paul J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

In transit metastases; Locoregional cutaneous recurrence; Lymphatic vascular invasion; Melanoma; Microscopic satellites

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; MELANOMA; PROGNOSIS; SKIN METASTASIS; TUMOR EMBOLISM;

EID: 0032954684     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0315-x     Document Type: Article

References (20)

1. Singletary SE, Balch CM. Recurrent regional metastases and their management. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S-J, eds. Cutaneous Melanoma. London: JB Lippincott, 1992:427-35.
2. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989;124:1051-5.
3. Singletary SE, Tucker SL, Boddie AW. Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer 1988;61:1437-40.
4. Pijpers R, Borgstein PJ, Meijer S, Hoehstra OS, van Hattum LH, Teule GJJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997;21:788-93.
5. Cascinelli N, Bufalino R, Marolda R, et al. Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol 1986;12: 175-80.
6. Gilchrist KW, Gilbert E, Metter G, Powers D. Importance of microscopic vascular invasion in primary cutaneous malignant melanoma. Surg Gvnecol Obstet 1977;145:559-61.
7. Schmoeckel C, Bockelbrink A, Bockelbrink H, Koutsis J, Braun-Falco O. Low- and high-risk malignant melanoma. I. Evaluation of clinical and histological prognosticators in 585 cases. Eur J Cancer Clin Oncol 1983;19:227-35.
8. Schmoeckel C, Bockelbrink A, Bockelbrink H, Braun-Falco O. Low- and high-risk malignant melanoma. II. Multivariate analyses for a prognostic classification. Eur J Cancer Clin Oncol 1983;19: 237-43.
9. Larsen TE, Grude TH. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. Acta Path Microbiol Scand 1979;87:131-8.
10. Johnson OK, Emrich LJ, Karakousis CP, Rao U, Greco WR. Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical stage I. Cancer 1985;55: 1107-17.
11. Day CL, Harrist TJ, Gorstein F, et al. Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg 1981;194:108-12.
12. León P, Daly JM, Synnestvedt M, Schultz DJ, Elder DE, Clark WH. The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg 1991;126:1461-8.
13. Karakousis CP, Choe KJ, Holyoke ED. Biologic behavior and treatment of intransit metastases of melanoma. Surg Gynecol Obstet 1980;150:29-32.
14. Roses DF, Harris MN, Rigel D, Carrey Z, Friedman R, Kopf AW. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg 1983;198:65-9.
15. Wong JH, Cagle LA, Kopald KH, Swisher SG, Morton DL. Natural history and selective management of in transit melanoma. J Surg Oncol 1990;44:146-50.
16. Lee Y-TM. Loco-regional primary and recurrent melanoma. III. Update of natural history and non-systemic treatments (1980-1987). Cancer Treatment Rev 1988;15:135-62.
17. Schraffordt-Koops H, Kroon BBR, Oldhoff J, Hoekstra HJ. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities. World J Surg 1992;16:241-5.
18. Vrouenraets BC, Nieweg OE, Kroon BBR. Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg 1996;83:1319-28.
19. Ghussen F, Krüger I, Smalley RV, Groth W. Hyperthermic perfusion with chemotherapy for melanoma of the extremities. World J Surg 1989;13:598-602.
20. Schraffordt-Koops H, Vaglini M, Kroon BBR, et al. Value of prophylactic isolated limb perfusion for stage I high risk malignant melanoma: a randomized phase III trial. Abstract. Melanoma Res 1997;7(suppl 1):S34.